Patent details
EP1325019 Title: ANTISENSE MODULATION OF CLUSTERIN EXPRESSION
Basic Information
- Publication number:
- EP1325019
- PCT Application Number:
- PCT/US/2001/028235
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP019707280
- PCT Publication Number:
- WO/2002/022635
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTISENSE MODULATION OF CLUSTERIN EXPRESSION
- French Title of Invention:
- MODULATION ANTISENS DE L'EXPRESSION DE LA CLUSTERINE
- German Title of Invention:
- ANTISENSE-MODULATION DER CLUSTERINEXPRESSION
- SPC Number:
Dates
- Filing date:
- 10/09/2001
- Grant date:
- 19/01/2011
- EP Publication Date:
- 19/01/2011
- PCT Publication Date:
- 21/03/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/07/2003
- EP B1 Publication Date:
- 19/01/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/09/2011
- Expiration date:
- 10/09/2021
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/09/2011
- Name:
- Isis Pharmaceuticals Inc.
- Address:
- 2855 Gazelle Court, Carlsbad, CA 92010, United States (US)
Inventor
1
- Name:
- MONIA Brett, P.
- Address:
- United States (US)
2
- Name:
- FREIER Susan, M.
- Address:
- United States (US)
Priority
- Priority Number:
- 659791
- Priority Date:
- 11/09/2000
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12N 15/113;
| Filing date | Document type | Number of pages |
|---|